Your views
Your feedback is vital to us as we continue to increase the quality of our services.
You are here:
Date: 26 December 2024
Time: 08:22
UHB researcher wins grant to further study
Story posted/last updated: 28 November 2012
A leading UK cancer research expert based at the School of Cancer Science at the University of Birmingham and the Queen Elizabeth Hospital Cancer Centre has been awarded a grant to support her innovative work.
Dr Chiara Margiotta, received the Promising Renal Investigators Meeting (PRIMe) Award for 2011 from pharmaceutical company Novartis.
She won the UK accolade following assessment by an international panel of experts and will receive a 10,000 euro (£8,270) grant to support the completion of a study that analyses blood and tissue samples from patients receiving tyrosine kinase inhibitors, in order to assess their safety and efficacy.
Tim Eisen, professor of medical oncology at the University of Cambridge and a member of the judging panel, said: "The innovation, vision and commitment displayed by this year's entrants and prize winners is very encouraging and promises to drive continued excellence in this field."
To view the full story please visit the HospitalPharma website.
University Hospitals Birmingham NHS Foundation Trust is not responsible for the contents or the reliability of external websites and does not necessarily endorse the views expressed within them. Listing should not be taken as endorsement of any kind. We cannot guarantee that links to other websites will work all of the time, and we have no control over the availability of external web pages.
Getting here
Information about travelling to, staying at and getting around the hospital.
Jobs at UHB
A great place to work. Learn why.
news@UHB
RSS feed
Subscribe to our news feed
